Safe Orthopaedics SA

ALSAF.PA

ALSAF.PASafe Orthopaedics SA undefined flag

Euronext Paris

0.00

EUR

+0.00

(+8.33%)

-30.00EPS

-NaNMarket Cap

Jun 30Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

FR001400F1V2

CUSIP

F7987L125

Return %

Stock

S&P500

-99.78

9.50

-100.00

58.73

-100.00

91.32

Use logarithmic scale

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Revenue per Share	108,666.67	322,333.33	684,333.33	66,631.58	59,625	67,608.7	46,905.41	4,380.26	1,228,000	912,200	80.91	- -
Basic EPS, GAAP	-1,117,000	-1,064,333.33	-1,645,333.33	-172,789.47	-150,125	-142,934.78	-78,378.38	-7,285.19	-2,768,666.67	-1,341,800	-96.16	- -
Free Cash Flow per Basic Share	-1,037,666.67	-1,327,666.67	-1,946,666.67	-184,815.79	-148,500	-107,173.91	-83,986.49	-3,920.48	-2,177,666.67	-1,643,000	-87.35	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	-949,333.33	-878,666.67	-1,339,000	-136,631.58	-113,775	-90,978.26	-22,608.11	-5,515.54	-1,644,000	-221,400	99.22	- -
Tangible Book Value per Share	285,000	-205,666.67	633,000	121,289.47	1,950	20,826.09	13,162.16	-4,125.23	-603,666.67	-324,800	-44.98	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sales/Revenue/Turnover	- -	1	2	3	2	3	3	5	4	5	6	6
Operating Margin (%)	-1,052.76	-319.86	-271.12	-285.07	-263.56	-174.73	-177.18	-155.45	-181	-166.21	-102.24	-105.59
Depreciation Expense	- -	- -	1	1	- -	- -	- -	- -	1	1	1	4
Net Income, GAAP	-3	-3	-5	-7	-6	-7	-6	-8	-8	-7	-7	-205
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	-1,027.91	-330.2	-240.43	-259.32	-251.78	-211.41	-167.1	-166.32	-225.46	-147.09	-118.84	-3,536.04
Working Capital	2	- -	2	7	5	5	5	- -	3	-1	-3	-267
LT Debt	1	1	1	3	6	5	5	6	8	5	5	3
Total Equity	1	- -	2	5	- -	1	1	-4	- -	- -	-1	-202
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	23.82%	13.28%	-0.87%
Net Income, GAAP	295.26%	575.18%	2,849.66%
Free Cash Flow	0.35%	-11.41%	-81.16%
Total Cash Common Dividend	- -	- -	- -
Total Equity	1,364.95%	2,960.69%	15,721.27%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Mr. Nicolas Papillon
Full Time Employees: 96
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Address: Parc des Bellevues Eragny-sur-Oise France 95610
IPO Date: Feb 10, 2015
Website: safeorthopaedics.com
Similar Companies: Top Glove Corporation Bhd. (7113.KL)
Shanghai Kindly Enterprise Development Group Co.,LTD. (603987.SS)
Stereotaxis, Inc. (STXS)
Lagis Enterprise Co., Ltd. (6730.TWO)
OJsys, Inc. (OJSY)
Allmed Medical Products Co., Ltd (002950.SZ)
Business: Safe Orthopaedics SA, a medical technology company, develops and markets sterile implants and single-use instruments for the treatment of spinal fracture pathologies in France and internationally. The company offers SteriSpine PS, an all-round kit for the treatment of spinal fractures and degenerative pathologies; and SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems. It also provides SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. The company was founded in 2010 and is headquartered in Éragny-sur-Oise, France.

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Revenue per Share	108,666.67	322,333.33	684,333.33	66,631.58	59,625	67,608.7	46,905.41	4,380.26	1,228,000	912,200	80.91	- -
Basic EPS, GAAP	-1,117,000	-1,064,333.33	-1,645,333.33	-172,789.47	-150,125	-142,934.78	-78,378.38	-7,285.19	-2,768,666.67	-1,341,800	-96.16	- -
Free Cash Flow per Basic Share	-1,037,666.67	-1,327,666.67	-1,946,666.67	-184,815.79	-148,500	-107,173.91	-83,986.49	-3,920.48	-2,177,666.67	-1,643,000	-87.35	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	-949,333.33	-878,666.67	-1,339,000	-136,631.58	-113,775	-90,978.26	-22,608.11	-5,515.54	-1,644,000	-221,400	99.22	- -
Tangible Book Value per Share	285,000	-205,666.67	633,000	121,289.47	1,950	20,826.09	13,162.16	-4,125.23	-603,666.67	-324,800	-44.98	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sales/Revenue/Turnover	- -	1	2	3	2	3	3	5	4	5	6	6
Operating Margin (%)	-1,052.76	-319.86	-271.12	-285.07	-263.56	-174.73	-177.18	-155.45	-181	-166.21	-102.24	-105.59
Depreciation Expense	- -	- -	1	1	- -	- -	- -	- -	1	1	1	4
Net Income, GAAP	-3	-3	-5	-7	-6	-7	-6	-8	-8	-7	-7	-205
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	-1,027.91	-330.2	-240.43	-259.32	-251.78	-211.41	-167.1	-166.32	-225.46	-147.09	-118.84	-3,536.04
Working Capital	2	- -	2	7	5	5	5	- -	3	-1	-3	-267
LT Debt	1	1	1	3	6	5	5	6	8	5	5	3
Total Equity	1	- -	2	5	- -	1	1	-4	- -	- -	-1	-202
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Safe Orthopaedics SA

Growth Rates

(avg. rate of change)

Company Description

Capital Structure

Working Capital

Quarterly Revenue

Year

Quarterly Earnings Per Share

Year

Quarterly Dividends Per Share

Year

Growth Rates

(avg. rate of change)

Year	Q1	Q2	Q3	Q4	FY
2021	- -	- -	- -	- -	-1,341,800
2022	- -	- -	- -	- -	-96.16
2023	- -	- -	- -	- -	- -